Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled study of inhaled bromhexine hydrochloride solution for sticky sputum symptoms in lower respiratory tract infections
CTR20212103Phase 3Active
- Sponsor
- Jiangxi Dongfu Pharmaceutical
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bromhexine in pulmonary infection, acute bronchitis, chronic bronchitis (CB), pulmonary tuberculosis (TB), pneumoconiosis, sponsored by Jiangxi Dongfu Pharmaceutical. Started Dec 2021; status: active.
02
Drugs
bromhexine
03
Conditions
pulmonary infectionacute bronchitischronic bronchitis (CB)pulmonary tuberculosis (TB)pneumoconiosis
Beyond the preview
Go deeper on CTR20212103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212103.